Physician
Mission Pathology Consultants, INC.
Mission Pathology Consultants, INC. was paid $2.77M by Medicaid between Jan 2018 and Nov 2024, across 171 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 26% of everything it billed.
33Billing provider infoMISSION PATHOLOGY CONSULTANTS, INC.
SANTA BARBARA, CA 93105
SANTA BARBARA, CA 93105
33aNPI1356409379assigned 12/04/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.77M
24GClaims786,440
24DCodes billed171
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#18 of 222
Median peer was paid$42K
This provider vs. median66×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 125,542 | $426K | |
| 2019 | 92,238 | $427K | |
| 2020 | 109,624 | $510K | |
| 2021 | 107,121 | $346K | |
| 2022 | 98,006 | $250K | |
| 2023 | 146,789 | $476K | |
| 2024incomplete | 107,120 | $338K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 26% | 9,725 | 9,559 | $722K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10.0% | 16,720 | 14,144 | $276K |
| 80053 | Comprehensive metabolic panel | 5.6% | 78,183 | 47,563 | $156K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 83,121 | 50,585 | $135K |
| 82805 | 4.1% | 13,349 | 7,348 | $113K | |
| 83735 | 3.3% | 56,182 | 17,706 | $93K | |
| 88307 | 2.8% | 898 | 894 | $77K | |
| 84145 | 2.6% | 15,388 | 9,978 | $73K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.4% | 747 | 690 | $66K |
| 85027 | 2.3% | 40,035 | 16,551 | $63K | |
| 80069 | 1.9% | 31,232 | 9,897 | $53K | |
| 82375 | 1.8% | 13,309 | 7,173 | $51K |
159 more codes
| 88342 | 1.6% | 1,011 | $43K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 2,222 | $37K |
| 84484 | 1.3% | 13,654 | $37K | |
| 88304 | 1.3% | 1,424 | $36K | |
| 83605 | 1.3% | 10,447 | $35K | |
| 87040 | 1.2% | 10,075 | $34K | |
| 87641 | <1% | 4,214 | $28K | |
| 83880 | <1% | 3,792 | $27K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,192 | $26K |
| 86140 | <1% | 24,803 | $24K | |
| 83690 | <1% | 15,942 | $23K | |
| 84100 | <1% | 23,774 | $23K | |
| 83615 | <1% | 18,433 | $23K | |
| 80320 | <1% | 7,603 | $22K | |
| 85610 | <1% | 19,297 | $20K | |
| 85007 | <1% | 24,678 | $19K | |
| 87632 | <1% | 571 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,326 | $18K |
| 85730 | <1% | 10,526 | $17K | |
| 82947 | <1% | 10,086 | $15K | |
| 83050 | <1% | 5,921 | $15K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,197 | $14K |
| 81001 | <1% | 22,497 | $14K | |
| 84703 | <1% | 8,622 | $13K | |
| 87077 | <1% | 6,139 | $12K | |
| 85060 | <1% | 1,104 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,211 | $11K |
| 88313 | <1% | 223 | $10K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 101 | $9K |
| 82948 | <1% | 4,572 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,285 | $9K |
| 89051 | <1% | 1,968 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,770 | $8K |
| 87070 | <1% | 4,216 | $8K | |
| 87186 | <1% | 4,060 | $8K | |
| 86850 | <1% | 10,837 | $8K | |
| 86900 | <1% | 13,589 | $8K | |
| 85379 | <1% | 4,145 | $8K | |
| 80074 | <1% | 761 | $8K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 613 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,134 | $7K |
| 86901 | <1% | 12,874 | $7K | |
| 81003 | <1% | 16,299 | $7K | |
| 88108 | <1% | 249 | $7K | |
| 82330 | <1% | 1,435 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,059 | $6K |
| 86945 | <1% | 1,026 | $6K | |
| 82550 | <1% | 3,605 | $5K | |
| 87631 | <1% | 396 | $5K | |
| 87205 | <1% | 4,783 | $5K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 35 | $5K |
| 80061 | Lipid panel | <1% | 1,945 | $5K |
| 88341 | <1% | 56 | $5K | |
| 87486 | <1% | 833 | $5K | |
| 84702 | <1% | 1,645 | $4K | |
| 83550 | <1% | 2,424 | $4K | |
| 82728 | <1% | 1,505 | $4K | |
| 80076 | <1% | 2,287 | $4K | |
| 84550 | <1% | 3,606 | $3K | |
| 87081 | <1% | 2,630 | $3K | |
| 87581 | <1% | 572 | $3K | |
| 88312 | <1% | 117 | $3K | |
| 80202 | <1% | 942 | $2K | |
| 82746 | <1% | 895 | $2K | |
| 85384 | <1% | 1,395 | $2K | |
| 80055 | <1% | 287 | $2K | |
| 83540 | <1% | 1,722 | $2K | |
| 84300 | <1% | 1,625 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 323 | $2K |
| 82247 | <1% | 1,794 | $2K | |
| 88189 | <1% | 24 | $2K | |
| 86704 | <1% | 691 | $2K | |
| 86706 | <1% | 766 | $2K | |
| 83930 | <1% | 837 | $1K | |
| 82140 | <1% | 480 | $1K | |
| 86803 | <1% | 523 | $1K | |
| 85018 | <1% | 3,146 | $1K | |
| 84439 | <1% | 768 | $1K | |
| 86880 | <1% | 1,170 | $1K | |
| 82570 | <1% | 1,194 | $1K | |
| 87102 | <1% | 589 | $1K | |
| 86710 | <1% | 415 | $1K | |
| 80047 | <1% | 662 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 185 | $1K |
| 80329 | <1% | 595 | $1K | |
| 87075 | <1% | 542 | $1K | |
| 85652 | <1% | 2,105 | $1K | |
| 87493 | <1% | 143 | $1K | |
| 87015 | <1% | 621 | $990.24 | |
| 87340 | <1% | 535 | $968.99 | |
| 85651 | <1% | 1,289 | $899.43 | |
| 88112 | <1% | 45 | $741.89 | |
| 87660 | <1% | 166 | $687.39 | |
| 80143 | <1% | 39 | $641.17 | |
| 80179 | <1% | 38 | $618.80 | |
| 87449 | <1% | 337 | $617.67 | |
| 83935 | <1% | 403 | $606.49 | |
| 84478 | <1% | 610 | $575.93 | |
| 87150 | <1% | 74 | $542.79 | |
| 84157 | <1% | 661 | $505.08 | |
| 82248 | <1% | 490 | $470.32 | |
| 87210 | <1% | 414 | $469.30 | |
| 87510 | <1% | 109 | $441.47 | |
| 87480 | <1% | 109 | $434.04 | |
| 85378 | <1% | 261 | $429.74 | |
| 85347 | <1% | 274 | $413.88 | |
| 82010 | <1% | 149 | $411.77 | |
| 88311 | <1% | 105 | $406.83 | |
| 86885 | <1% | 325 | $396.55 | |
| 82945 | <1% | 437 | $366.29 | |
| 88141 | <1% | 28 | $353.92 | |
| 85380 | <1% | 299 | $342.76 | |
| 85520 | <1% | 150 | $340.40 | |
| 82565 | <1% | 292 | $306.32 | |
| 85670 | <1% | 301 | $300.02 | |
| 87147 | <1% | 166 | $298.91 | |
| 84295 | <1% | 157 | $243.91 | |
| 87324 | <1% | 125 | $226.75 | |
| 82950 | <1% | 219 | $221.44 | |
| 82105 | <1% | 81 | $211.52 | |
| 87116 | <1% | 91 | $208.56 | |
| 86592 | <1% | 248 | $194.44 | |
| 82272 | <1% | 98 | $191.19 | |
| 82533 | <1% | 46 | $190.99 | |
| 88300 | <1% | 21 | $161.70 | |
| 82784 | <1% | 68 | $160.30 | |
| 86677 | <1% | 48 | $147.13 | |
| 87481 | <1% | 24 | $143.92 | |
| 86308 | <1% | 128 | $133.66 | |
| 84134 | <1% | 38 | $126.97 | |
| 82043 | <1% | 87 | $109.62 | |
| 89190 | <1% | 25 | $103.33 | |
| 84030 | <1% | 80 | $90.60 | |
| 82607 | <1% | 33 | $87.45 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,097 | $84.00 |
| 85576 | <1% | 26 | $79.16 | |
| 84075 | <1% | 97 | $77.45 | |
| 84460 | <1% | 98 | $66.95 | |
| 84450 | <1% | 98 | $65.71 | |
| 86318 | <1% | 21 | $64.79 | |
| 86780 | <1% | 24 | $55.64 | |
| 86141 | <1% | 19 | $53.11 | |
| 84155 | <1% | 99 | $52.01 | |
| 85046 | <1% | 42 | $50.27 | |
| 84132 | <1% | 49 | $47.64 | |
| 85045 | <1% | 48 | $43.03 | |
| 84156 | <1% | 65 | $41.88 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 740 | $37.50 |
| 84165 | <1% | 43 | $36.50 | |
| 85014 | <1% | 57 | $30.66 | |
| 85044 | <1% | 26 | $24.44 | |
| 82977 | <1% | 21 | $21.48 | |
| 86430 | <1% | 12 | $14.76 | |
| 87181 | <1% | 27 | $14.47 | |
| 86923 | <1% | 19 | $12.25 | |
| 84520 | <1% | 12 | $10.20 | |
| 84315 | <1% | 12 | $6.85 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 177 | $0.00 |
| 87154 | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACOBSON, LAUREN (PRESIDENT)